EHD2 and breast cancer: By KM Plotter analysis, combined EHD2-, CAV1-, and CAV2-high basal (PAM50-based) but not all BC patients showed significantly shorter distal metastasis-free survival (Figure 7B, Figure 7—figure supplement 1B).